Priya Singhal
Corporate Officer/Principal presso BIOGEN INC.
Patrimonio netto: 1 M $ in data 31/05/2024
Profilo
Priya Singhal is currently the Chief Medical Officer at Biogen, Inc. She previously worked as the Head-Medical Affairs & Vice President at Vertex Pharmaceuticals, Inc. from 2008 to 2012.
She also held a position as the Head-Research & Development at Zafgen, Inc. Dr. Singhal holds a doctorate degree from the University of Mumbai and a graduate degree from Harvard T.H.
Chan School of Public Health.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
BIOGEN INC.
0.00% | 02/04/2024 | 4 886 ( 0.00% ) | 1 M $ | 31/05/2024 |
Posizioni attive di Priya Singhal
| Società | Posizione | Inizio |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 02/10/2023 |
Precedenti posizioni note di Priya Singhal
| Società | Posizione | Fine |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Direttore Tecnico/Scientifico/R&S | 01/01/2012 |
| LARIMAR THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Priya Singhal
| Harvard T.H. Chan School of Public Health | Graduate Degree |
| University of Mumbai | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| Aziende private | 1 |
|---|---|
Zafgen, Inc.
 Zafgen, Inc. BiotechnologyHealth Technology Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Priya Singhal
